Concepedia

Filip Charlier

FC

Statistics

Publications

4

Citations

586

H-Index

4

Active since

2006

Affiliations

Uppsala University(Current)

Imelda Hospital

Technical University of Munich

Filip Charlier is an author at Uppsala University specializing in cardiology, medicine, and pharmacology.

Publications per year

2006–2022

4

Publications

4

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Unifocal Right-Sided Ablation Treatment for Neurally Mediated Syncope and Functional Sinus Node Dysfunction Under Computed Tomographic Guidance

Philippe Debruyne, Tom Rossenbacker, Christine Collienne et al. · Circulation Arrhythmia and Electrophysiology · 2018 · 111 citations · Full text

Medicine, Cardiology, Cardiothoracic Surgery +9

Interleukin 6 and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Chronic Coronary Syndrome

Gorav Batra, Tatevik Ghukasyan Lakic, Johan Lindbäck et al. · JAMA Cardiology · 2021 · 111 citations · Full text

Medicine, Cardiology, Immunology +15

Recombinant P-selectin glycoprotein ligand–immunoglobulin, a P-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The P-Selectin Antagonist Limiting Myonecrosis (PSALM) trial

Paul Mertens, Alex Maes, Johan Nuyts et al. · American Heart Journal · 2006 · 53 citations

Medicine, Cardiology, Pharmacology +12

1–4 of 4